Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease
Clinical trial NCT03283059 · UNKNOWN
Trial details
- NCT number
- NCT03283059
- Sponsor
- Shanghai Mental Health Center
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-16
- Primary completion
- 2020-09-16
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.